nach oben

Erschienen in:

01.05.2015 | Original Paper

Profiles of Risk Among HIV-Infected Youth in Clinic Settings

verfasst von: M. Isabel Fernández, Heather C. Huszti, Patrick A. Wilson, Shoshana Kahana, Sharon Nichols, René Gonin, Jiahong Xu, Bill G. Kapogiannis

Erschienen in: AIDS and Behavior | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite the rising number of new HIV infections among youth, few tailored interventions for youth living with HIV (YLH) have been developed and rigorously tested. Developing tailored interventions necessitates identifying different profiles of YLH and understanding how risk and protective factors cluster together. Obtaining this critical information requires accessing a sufficiently large sample of YLH from diverse geographic settings such as those available through the Adolescent Trials Network for HIV Interventions (ATN). We recruited a cross-sectional sample of 1,712 YLH from ATN clinics; participants completed a survey on psychosocial and health factors. Using latent class analysis on nine composite variables representing risk factors, we identified five classes distinguished by substance use, sexual behavior, and pregnancy history and differing on health outcomes. Findings suggest a need for tailored interventions addressing multiple risky behaviors of HIV-infected youth and research to clarify how intervention effectiveness may differ by risk profile.

Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–80.CrossRefPubMed

Centers for Disease Control and Prevention. CDC Fact Sheet New HIV Infections in the United States,. http://www.cdc.gov/nchhstp/newsroom/docs/2012/HIV-Infections-2007-2010.pdf. Published December 2012. Accessed 26 Sept 2013.

Phillips G II, Wohl A, Xavier J, Jones K, Hidalgo J. Epidemiologic data on young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S3–8.CrossRefPubMed

Marshall K, Crepaz N, O’Leary A. A systematic review of evidence-based behavioral interventions for African American youth at risk for HIV/STI infection, 1988-2007. In: McCree DH, et al., editors. African Americans and HIV/AIDS. New York: Springer; 2010. p. 151–80.CrossRef

Robin L, Dittus P, Whitaker D, et al. Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health. 2004;34(1):3–26.CrossRefPubMed

Leonard AD, Markham CM, Bui T, Shegog R, Paul ME. Lowering the risk of secondary HIV transmission: insights from HIV-positive youth and health care providers. Perspect Sex Reprod Health. 2010;42(2):110–6.CrossRefPubMedCentralPubMed

Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.PubMedCentralPubMed

Rotheram-Borus MJ, Lee MB, Murphy DA, et al. Efficacy of a preventive intervention for youths living with HIV. Am J Public Health. 2001;91(3):400–5.CrossRefPubMedCentralPubMed

Naar-King S, Wright K, Parsons JT, et al. Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS Educ Prev. 2006;18(1):1–11.CrossRefPubMed

10.

Chen X, Murphy DA, Naar-King S, Parsons JT, Adolescent Medicine Trials Network for HIV, AIDS Intervention. A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV. J Adolesc Health. 2011;49(2):193–8.CrossRefPubMedCentralPubMed

11.

Rotheram-Borus MJ, Murphy DA, Kennedy M, Stanton A, Kuklinski M. Health and risk behaviors over time among youth living with HIV. J Adolesc. 2001;24(6):791–802.CrossRefPubMed

12.

Murphy DA, Durako SJ, Mosicki AB, et al. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health. 2001;29(3 Suppl):57–63.CrossRefPubMed

13.

Kadivar H, Garvie PA, Sinnock C, Heston JD, Flynn PM. Psychosocial profile of HIV-infected adolescents in a Southern US Urban cohort. AIDS Care. 2006;18(6):544–9.CrossRefPubMed

14.

Centers for Disease Control and Prevention. Vials signs: HIV infection, testing, and risk behaviors among youths—United States. MMWR Morb Mortal Wkly Rep. 2012;61(47):971–6.

15.

Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47(4):577–84.CrossRefPubMed

16.

Stein JA, Rotheram-Borus MJ, Swendeman D, Milburn NG. Predictors of sexual transmission risk behaviors among HIV-positive young men. AIDS Care. 2005;17(4):433–42.CrossRefPubMedCentralPubMed

17.

Di Risio M, Ballantyne PJ, Read SE, Bendayan R. “HIV isn’t me…”: HIV+ adolescents experiences in a positive context of support and treatment. Aids Care. 2011;23(6):694–9.CrossRefPubMed

18.

Charmaz K. The body, identity, and self: adapting to impairment. Sociol Q. 1995;36(4):657–80.CrossRef

19.

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedCentralPubMed

20.

Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13(3):595–605.CrossRefPubMed

21.

Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro MG, Organization WH. Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010.

22.

Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607–14.CrossRefPubMed

23.

Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.CrossRefPubMed

24.

Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. New York: Wiley; 2010.

25.

Gaughan DM, Hughes MD, Oleske JM, et al. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004;113(6):e544–51.CrossRefPubMed

26.

Misdrahi D, Vila G, Funk-Brentan I, Tardieu M, Blanche S, Mouren-Simeoni MC. DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1). Eur Psychiatry. 2004;19(3):182–4.CrossRefPubMed

27.

Pao M, Lyon M, D’Angelo LJ, et al. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154(3):240–4.CrossRefPubMed

28.

Mulligan K, Harris DR, Emmanuel P, et al. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network protocol 021b. In: 18th Conference on retroviruses and opportunistic infections. Boston, March 2011.

29.

Havens PL, Hazra R, Stephensen C, et al. Vitamin D3 supplementation decreases parathyroid hormone (PTH) in HIV-infected youth being treated with tenofovir-containing combination antiretroviral therapy: a randomized, double-blind, placebo-controlled multicenter trial: Adolescent Trials Network protocol 063. In: 18th Conference on retroviruses and opportunistic infections. Boston, March 2011.

30.

CDC. Youth risk behavior surveillance—United States, 2007. MMWR. 2008;57(SS04):1–131.

31.

Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.CrossRefPubMed

32.

Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337(19):1343–9.CrossRefPubMed

33.

Vyzula R, Remick SC. Lung cancer in patients with HIV-infection. Lung Cancer. 1996;15(3):325–39.CrossRefPubMed

34.

Clifford GM, Lise M, Franceschi S, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer. 2012;106(3):447–52.CrossRefPubMedCentralPubMed

35.

Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(4):374–83.CrossRefPubMed

36.

Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10(10):1121–6.PubMed

37.

Morris A, George MP, Crothers K, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc. 2011;8(3):320–5.CrossRefPubMedCentralPubMed

38.

Hirani A, Cavallazzi R, Vasu T, et al. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med. 2011;105(11):1655–61.CrossRefPubMed

39.

Treisman GJ, Angelino AF, Hutton HE. Psychiatric issues in the management of patients with HIV infection. JAMA. 2001;286(22):2857–64.CrossRefPubMed

40.

Tassiopoulos K, Moscicki AB, Mellins C, et al. Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis. 2013;56(2):283–90. doi:10.1093/cid/cis816.CrossRefPubMedCentralPubMed

41.

Alperen J, Brummel S, Tassiopoulos K, et al. Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth. J Adolesc Health. 2014;54(3):341–9. doi:10.1016/j.jadohealth.2013.09.003.CrossRefPubMedCentralPubMed

42.

Mellins CA, Elkington KS, Leu CS, et al. Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth. AIDS Care. 2012;24(8):953–62. doi:10.1080/09540121.2012.668174.CrossRefPubMedCentralPubMed

43.

Fair C, Wiener L, Zadeh S, et al. Reproductive health decision-making in perinatally HIV-infected adolescents and young adults. Matern Child Health J. 2013;17(5):797–808. doi:10.1007/s10995-012-1070-3.CrossRefPubMedCentralPubMed

44.

Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–54.CrossRefPubMed

45.

Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol. 2004;23(4):363–70.CrossRefPubMed

46.

McGowan JP, Shah SS, Ganea CE, et al. Risk behavior for transmission of Human Immunodeficiency Virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis. 2004;1(38):122–7.CrossRef

47.

Klinkenberg WD, Sacks S, HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22–42.CrossRefPubMed

48.

(SAMHSA), C.f.S.A.T., Substance Abuse Treatment for Persons With Co-Occurring Disorders, C.f.S.A. Treatment, editors. Rockville: Substance Abuse and Mental Health Services Administration; 2005.

49.

Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care. 2002;14(Suppl 1):S31–44.CrossRefPubMed

50.

Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care. 2002;14(Suppl 1):S45–57.CrossRefPubMed

51.

Magnus M, Schmidt N, Kirkhart K, et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care STDS. 2001;15(3):137–45.CrossRefPubMed

52.

Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. Am J Epidemiol. 2000;152(2):99–106.CrossRefPubMed

53.

Nichols SL, Lowe A, Zhang X, et al. Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth. Drug Alcohol Depend. 2014;1(134):376–82.CrossRef

Titel: Profiles of Risk Among HIV-Infected Youth in Clinic Settings
verfasst von: M. Isabel Fernández
Heather C. Huszti
Patrick A. Wilson
Shoshana Kahana
Sharon Nichols
René Gonin
Jiahong Xu
Bill G. Kapogiannis
Publikationsdatum: 01.05.2015
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 5/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-014-0876-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Profiles of Risk Among HIV-Infected Youth in Clinic Settings

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa

The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations

Foreign-Born Persons Diagnosed with HIV: Where are They From and Where Were They Infected?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin